Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease

Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Nov 12, 2021

Keywords

ClinConnect Summary

This clinical trial is studying a new way to help people with Chronic Obstructive Pulmonary Disease (COPD) recover after being hospitalized. Specifically, it compares a video telehealth program, where patients can join rehabilitation sessions remotely from home, to the usual care they would receive. The goal is to see if this video program can help reduce the chances of being readmitted to the hospital and improve overall lung health. Researchers are also looking into whether this method is cost-effective.

To join the trial, participants need to be at least 40 years old and have been hospitalized for a worsening of their COPD. They should be willing to follow the study's procedures and give consent. However, people with certain serious heart problems, other significant lung diseases, or cognitive issues that would make it hard to follow along in the program may not be eligible. If someone joins, they can expect to participate in video sessions that focus on exercises and education about managing COPD, all while being supported by a team of healthcare professionals.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age 40 or greater
• • 2. Clinical diagnosis of COPD
• • 3. Hospitalized for acute exacerbation of COPD.
• • 4. Be willing to adhere to trial and follow-up procedures and give informed consent
• Exclusion Criteria:
• • 1. Secondary diagnosis of congestive heart failure that is severe as documented by active symptoms, New York Heart Association (NYHA) functional classification IV or left ventricular ejection fraction \<25% on echocardiography
• • 2. Other respiratory conditions that could confound the diagnosis such as asthma, pulmonary fibrosis, bronchiectasis, and lung cancer. Participants with pneumonic exacerbations of COPD will be included.
• • 3. Primary diagnosis of COVID pneumonia. Individuals with incidentally detected COVID or persistently positive for COVID but deemed to be convalescent will not be excluded.
• • 4. Active cancers on chemotherapy or radiation therapy
• • 5. Immunosuppressed states predisposing to frequent hospitalizations including uncontrolled HIV/AIDS
• • 6. Active or recent (within 1 month) myocardial infarction
• • 7. Angina not well-controlled by medication
• • 8. Unstable cardiac arrhythmias, atrial or ventricular
• • 9. Supplemental oxygen requirement greater than 5 liters per minute at either rest or with exertion
• • 10. Significant cognitive dysfunction, including dementia, that in opinion of investigator would impair ability to safely or effectively engage in study protocol
• • 11. Participants with any terminal medical illnesses as diagnosed by a physician, and/or on hospice
• • 12. Currently enrolled in and participating in pulmonary rehabilitation
• • 13. Treatment with chronic or newly initiated home ventilatory support. Those on in-patient short-term non-invasive ventilation will not be excluded.
• • 14. Special patient groups such as prisoners and institutionalized patients
• • 15. Participants with musculoskeletal comorbidities or physical infirmities that preclude participation in an exercise program
• • 16. Current participation in any other interventional clinical trial
• • 17. Inability to understand and speak English during exercise sessions
• • 18. Inability or unwillingness to comply with study and/or follow-up procedures outlined in the protocol